Abstract: The invention relates to biomarkers which may be used individually or in combination to diagnose osteoarthritis. In particular, it relates to the use of one or more of V65 vitronectin fragment or fragments, variants or degradation products thereof; complement fragment C3f or fragments, variants or degradation products thereof; or a decreased concentration of CTAPIII protein or fragments, variants or degradation products thereof, as a marker of osteoarthritis.
Type:
Application
Filed:
January 31, 2012
Publication date:
February 6, 2014
Applicants:
L'University de Liege, UNIVERSITY OF BRISTOL, CENTRE HOSPITALIER UNIVERSITAIRE LIEGOIS
Inventors:
Mohammed Sharif, Michel Malaise, Dominique De Seny